Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Study ID
NCT02705300

Study type
Interventional

Study phase
Phase 2

Study status
Active, not recruiting

Trial Acronym

Trial Summary

Treatment with FOLFOXIRI (5-fluorouracil, oxaliplatin, irinotecan) can be effective, but it has serious side effects, which may require hospitalization. The purpose of this study is to investigate whether the addition of tocotrienol can reduce the side effects to FOLFOXIRI otherwise leading to hospitalization.

More informations

Trial Starting Date

May 06,2016

Requirements

Gender All
Minimum age 18 Years
Maximum age 75 Years

Enrollement Limit